Abstract
Objectives:Plasma viscosity (PV) is a major determinant of capillary blood flow through the microcirculation, which, if impaired, can result in potentially important clinical sequelae. The objectives of this study were to investigate the alterations of PV values in different stages of cirrhosis, and to determine if any change in PV correlates with Child score or Model for End-Stage Liver Disease (MELD) score or has any prognostic significance.Method:The study included 92 patients with cirrhosis and 28 healthy volunteers. Upper endoscopic and ultrasonographic examinations of the patients were obtained. Serum biochemistry fibrinogen, complete blood count, C-reactive protein (CRP), and lipid profile were performed. PV was determined using a rotational viscosimeter.Results:PV decreased with the progression in Child scores (Child A: 1.46 ± 0.20 mPa-s, Child B: 1.33 ± 0.21 mPa-s, Child C: 1.12 ± 0.15 mPa-s), (P < 0.001). A similar change was detected between the MELD score and PV (P < 0.001). There was a positive correlation between the total protein, albumin and plasma viscosity in the control group, but a similar relationship was not found in cirrhotic patients. History of hepatic encephalopathy (30 of 92 patients) was independently associated with decreased PV (P = 0.003).Conclusion:We observed that increasing Child and MELD scores were significantly associated with lower PV levels irrespective of biochemical and hematologic values. These observations support the concept that hemorheologic changes in cirrhotic patients might be either the cause or the result of a pathophysiological process, and it may not be easy to distinguish between these two possibilities.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Bosch J, Pizcueta P, Feu F, et al. Pathophysiology of portal hypertension. Gastroenterol Clin North Am 1992;21:1–14.BoschJ]]PizcuetaP]]FeuF&etal;Pathophysiology of portal hypertension.Gastroenterol Clin North Am1992211-142. Groszmann RJ, Garcia-Tsao G, Bosch J, et al; Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254–2261.GroszmannRJ]]Garcia-TsaoG]]BoschJ&etal;Portal Hypertension Collaborative GroupBeta-blockers to prevent gastroesophageal varices in patients with cirrhosis.N Engl J Med20053532254-22613. Cokelet GR. Poiseuille Award Lecture. Viscometric, in vitro and in vivo blood viscosity relationships: how are they related? Biorheology 1999;36:343–358.CokeletGRPoiseuille Award Lecture. Viscometric, in vitro and in vivo blood viscosity relationships: how are they related?Biorheology199936343-3584. Sikuler E. Portal hypertension and blood viscosity. J Clin Gastroenterol 2007;41(suppl 3):S262–S265.SikulerEPortal hypertension and blood viscosity.J Clin Gastroenterol200741S262-S2655. Reinhart WH. Molecular biology and self-regulatory mechanisms of blood viscosity: a review. Biorheology 2001;38:203–212.ReinhartWHMolecular biology and self-regulatory mechanisms of blood viscosity: a review.Biorheology200138203-2126. Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost 2003;29:435–450.BaskurtOK]]MeiselmanHJBlood rheology and hemodynamics.Semin Thromb Hemost200329435-4507. Matas C, Joven J, Vilella E, et al. Lipoprotein alterations in liver cirrhosis: a possible contribution to changes in plasma oncotic pressure and viscosity. J Hepatol 1997;27:639–644.MatasC]]JovenJ]]VilellaE&etal;Lipoprotein alterations in liver cirrhosis: a possible contribution to changes in plasma oncotic pressure and viscosity.J Hepatol199727639-6448. Barnes A, Willars E. Diabetes, in Chien S, Dormandy J, Ernst E (eds): Clinical Hemorheology. Dordrecht, The Netherlands, Martinus Nijhoff Publishers, 1987, pp 275–309.BarnesA]]WillarsEDiabetesChien S, Dormandy J, Ernst EClinical Hemorheology.Dordrecht, The NetherlandsMartinus Nijhoff Publishers1987275-3099. Rosenson RS, Shott S, Katz R. Elevated blood viscosity in systemic lupus erythematosus. Semin Arthritis Rheum 2001;31:52–57.RosensonRS]]ShottS]]KatzRElevated blood viscosity in systemic lupus erythematosus.Semin Arthritis Rheum20013152-5710. Erdil A, Tüzün A, Yönem A, et al. Blood viscosity changes in patients with liver cirrhosis. T Klin Gastroenterohepatol 2001;12:25–31.ErdilA]]TüzünA]]YönemA&etal;Blood viscosity changes in patients with liver cirrhosis.T Klin Gastroenterohepatol20011225-3111. Tamer S, Cefle K, Gokkusu C, et al. Comparison of rheological parameters in patients with post hepatitic and alcoholic cirrhosis. Clin Hemorheol Microcirc 2007;36:247–252.TamerS]]CefleK]]GokkusuC&etal;Comparison of rheological parameters in patients with post hepatitic and alcoholic cirrhosis.Clin Hemorheol Microcirc200736247-25212. Liu TT, Wong WJ, Hou MC, et al. Hemorheology in patients with liver cirrhosis: special emphasis on its relation to severity of esophageal variceal bleeding. J Gastroenterol Hepatol 2006;21:908–913.LiuTT]]WongWJ]]HouMC&etal;Hemorheology in patients with liver cirrhosis: special emphasis on its relation to severity of esophageal variceal bleeding.J Gastroenterol Hepatol200621908-91313. Meiselman HJ, Baskurt OK. Hemorheology and hemodynamics: dove andare? Clin Hemorheol Microcirc 2006;35:37–43.MeiselmanHJ]]BaskurtOKHemorheology and hemodynamics: dove andare?Clin Hemorheol Microcirc20063537-4314. Palme G, Kochen M, Leonhardt H. [Changes of blood-flow properties in patients with chronic liver disease (author’s transl)]. Clin Chim Acta 1975;61:163–169 [in German].15. Polio J, Groszmann RJ. Pharmacological control of portal hypertension. Prog Liver Dis 1993;11:231–249.PolioJ]]GroszmannRJPharmacological control of portal hypertension.Prog Liver Dis199311231-24916. Visentin I, Mares M, Bertolo C, et al. [Erythrocyte filterability and relative viscosity in liver cirrhosis and chronic hepatitis]. Clin Ter 1989;129:243–259 [in Italian].17. Tamer S, Cefle K, Palanduz S, et al. Rheological properties of blood in patients with chronic liver disease. Clin Hemorheol Microcirc 2002;26:9–14.TamerS]]CefleK]]PalanduzS&etal;Rheological properties of blood in patients with chronic liver disease.Clin Hemorheol Microcirc2002269-1418. Leonhardt H, Bungert HJ. [Plasma viscosity and portal hypertension in liver cirrhosis (author’s transl)]. Klin Wochenschr 1973;21:1043–1049 [in German].19. Woodward M, Lowe G, Rumley A, et al. Measurement of plasma viscosity in stored frozen samples: a general population study. Blood Coagul Fibrinolysis 2003;14:417–420.WoodwardM]]LoweG]]RumleyA&etal;Measurement of plasma viscosity in stored frozen samples: a general population study.Blood Coagul Fibrinolysis200314417-42020. Leblond PE. Hemorheology and Blood Diseases, in Chien S, Dormandy J, Ernst E, et al (eds): Clinicals Hemorheology. Dordrecht, Martinus Nijhoff Publishers, 1987, pp 227–254.LeblondPEHemorheology and Blood DiseasesChien S, Dormandy J, Ernst E, et alClinicals Hemorheology.DordrechtMartinus Nijhoff Publishers1987227-254
